| scholarly article | Q13442814 |
| P50 | author | Anna Smed-Sörensen | Q88257244 |
| P2093 | author name string | Norihiro Nakamura | |
| Ira Mellman | |||
| Peter Lauer | |||
| Lélia Delamarre | |||
| Cécile Chalouni | |||
| Tibor Keler | |||
| Bithi Chatterjee | |||
| Richard Vandlen | |||
| Dirk Brockstedt | |||
| Byoung-Chul Lee | |||
| Lillian Cohn | |||
| Filipp Esselborn | |||
| P2860 | cites work | Selective suicide of cross-presenting CD8+ dendritic cells by cytochrome c injection shows functional heterogeneity within this subset | Q24652686 |
| DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes | Q24682603 | ||
| Chloroquine enhances human CD8+ T cell responses against soluble antigens in vivo | Q27485211 | ||
| Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity | Q27489852 | ||
| Dendritic cells and the control of immunity | Q27860918 | ||
| Sec22b regulates phagosomal maturation and antigen crosspresentation by dendritic cells | Q28119175 | ||
| BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood | Q28138201 | ||
| Autoimmunity in MFG-E8-deficient mice is associated with altered trafficking and enhanced cross-presentation of apoptotic cell antigens | Q28388910 | ||
| Differential antigen processing by dendritic cell subsets in vivo | Q29615177 | ||
| Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo | Q30080006 | ||
| Monocyte-Derived Dendritic Cells Exhibit Increased Levels of Lysosomal Proteolysis as Compared to Other Human Dendritic Cell Populations | Q33651251 | ||
| Differential susceptibility to human immunodeficiency virus type 1 infection of myeloid and plasmacytoid dendritic cells | Q33884007 | ||
| Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. | Q33902330 | ||
| The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells | Q33902379 | ||
| Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells | Q33902421 | ||
| CD27 is required for generation and long-term maintenance of T cell immunity | Q33924191 | ||
| Cell biology of antigen processing in vitro and in vivo | Q33985828 | ||
| Influenza A virus infection of human primary dendritic cells impairs their ability to cross-present antigen to CD8 T cells | Q34192846 | ||
| Regulation of T cell immunity by dendritic cells | Q34339191 | ||
| Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A. | Q34573130 | ||
| Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. | Q34623431 | ||
| Plasmacytoid dendritic cells control T-cell response to chronic viral infection. | Q35779317 | ||
| Characterization of resident and migratory dendritic cells in human lymph nodes | Q35894149 | ||
| The dendritic cell receptor DNGR-1 controls endocytic handling of necrotic cell antigens to favor cross-priming of CTLs in virus-infected mice | Q35913706 | ||
| Resident CD141 (BDCA3)+ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation | Q35946105 | ||
| A subset of dendritic cells induces CD4+ T cells to produce IFN-gamma by an IL-12-independent but CD70-dependent mechanism in vivo. | Q36229330 | ||
| Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling | Q36673501 | ||
| KBMA Listeria monocytogenes is an effective vector for DC-mediated induction of antitumor immunity | Q36964813 | ||
| NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells. | Q37002001 | ||
| Antigen-presentation properties of plasmacytoid dendritic cells | Q37272231 | ||
| Inflammatory signals in dendritic cell activation and the induction of adaptive immunity | Q37361473 | ||
| Targeting proteins to distinct subcellular compartments reveals unique requirements for MHC class I and II presentation | Q37363754 | ||
| Dendritic cell subsets in primary and secondary T cell responses at body surfaces | Q37633373 | ||
| Intracellular mechanisms of antigen cross presentation in dendritic cells | Q37695674 | ||
| The CD8+ dendritic cell subset | Q37700814 | ||
| Comparative genomics as a tool to reveal functional equivalences between human and mouse dendritic cell subsets | Q37700838 | ||
| A modular and combinatorial view of the antigen cross-presentation pathway in dendritic cells. | Q37903403 | ||
| Protein-mediated membrane fusion | Q38648025 | ||
| DNGR-1 is a specific and universal marker of mouse and human Batf3-dependent dendritic cells in lymphoid and nonlymphoid tissues | Q39374974 | ||
| Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8+ and CD4+ T cell responses with broad antigen specificity | Q39621141 | ||
| Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells | Q40952120 | ||
| Phagosomal proteolysis in dendritic cells is modulated by NADPH oxidase in a pH-independent manner | Q41164914 | ||
| Route of antigen uptake differentially impacts presentation by dendritic cells and activated monocytes | Q41578289 | ||
| Replication-dependent potent IFN-alpha induction in human plasmacytoid dendritic cells by a single-stranded RNA virus | Q41913203 | ||
| Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation | Q42861996 | ||
| Effects of low pH on influenza virus. Activation and inactivation of the membrane fusion capacity of the hemagglutinin | Q45829893 | ||
| The small GTPase Rac2 controls phagosomal alkalinization and antigen crosspresentation selectively in CD8(+) dendritic cells | Q46071205 | ||
| Introduction of soluble protein into the class I pathway of antigen processing and presentation | Q46305448 | ||
| Developmental control of endocytosis in dendritic cells by Cdc42. | Q50119612 | ||
| The inflammatory cytokine, GM-CSF, alters the developmental outcome of murine dendritic cells. | Q50795170 | ||
| Cutting Edge: TLR-Dependent viral recognition along with type I IFN positive feedback signaling masks the requirement of viral replication for IFN-{alpha} production in plasmacytoid dendritic cells. | Q51758901 | ||
| Targeting DC-SIGN via its neck region leads to prolonged antigen residence in early endosomes, delayed lysosomal degradation, and cross-presentation. | Q51765801 | ||
| Human dendritic cell subsets from spleen and blood are similar in phenotype and function but modified by donor health status. | Q51869621 | ||
| NOX2 Controls Phagosomal pH to Regulate Antigen Processing during Crosspresentation by Dendritic Cells | Q58007061 | ||
| The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells | Q58619899 | ||
| The Acquisition of Antigen Cross-Presentation Function by Newly Formed Dendritic Cells | Q58757859 | ||
| Differential processing of autoantigens in lysosomes from human monocyte-derived and peripheral blood dendritic cells | Q81375587 | ||
| Characterization of four conventional dendritic cell subsets in human skin-draining lymph nodes in relation to T-cell activation | Q84547662 | ||
| Internalization and endosomal degradation of receptor-bound antigens regulate the efficiency of cross presentation by human dendritic cells | Q84569562 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dendritic cell | Q506253 |
| P304 | page(s) | 1049-1063 | |
| P577 | publication date | 2013-04-08 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentation | |
| P478 | volume | 210 |
| Q38576179 | A Comparative Study of the T Cell Stimulatory and Polarizing Capacity of Human Primary Blood Dendritic Cell Subsets. |
| Q92815242 | A DNA-Modified Live Vaccine Prime-Boost Strategy Broadens the T-Cell Response and Enhances the Antibody Response against the Porcine Reproductive and Respiratory Syndrome Virus |
| Q28354202 | A Universal Influenza Vaccine Can Lead to Disease Exacerbation or Viral Control Depending on Delivery Strategies |
| Q90256862 | A subset of CD1c+ dendritic cells is increased in patients with tuberculosis and promotes Th17 cell polarization |
| Q38169709 | An updated view of the intracellular mechanisms regulating cross-presentation |
| Q41930681 | Antigen Cross-Presentation and T-Cell Cross-Priming In Cancer Immunology And Immunotherapy |
| Q37689507 | Antigen cross-presentation of immune complexes |
| Q35904260 | Antigen delivery by filamentous bacteriophage fd displaying an anti-DEC-205 single-chain variable fragment confers adjuvanticity by triggering a TLR9-mediated immune response |
| Q91749113 | Arc/Arg3.1 defines dendritic cells and Langerhans cells with superior migratory ability independent of phenotype and ontogeny in mice |
| Q64253586 | Are Conventional Type 1 Dendritic Cells Critical for Protective Antitumor Immunity and How? |
| Q64260954 | Beyond cDC1: Emerging Roles of DC Crosstalk in Cancer Immunity |
| Q55092014 | CLEC10A Is a Specific Marker for Human CD1c+ Dendritic Cells and Enhances Their Toll-Like Receptor 7/8-Induced Cytokine Secretion. |
| Q39448429 | CLEC12A-Mediated Antigen Uptake and Cross-Presentation by Human Dendritic Cell Subsets Efficiently Boost Tumor-Reactive T Cell Responses. |
| Q38780081 | CXCL4 Exposure Potentiates TLR-Driven Polarization of Human Monocyte-Derived Dendritic Cells and Increases Stimulation of T Cells. |
| Q35161496 | Circulating precursors of human CD1c+ and CD141+ dendritic cells |
| Q37524465 | Controlling immune responses by targeting antigens to dendritic cell subsets and B cells |
| Q26799991 | Cross-Presentation of Cell-Associated Antigens by MHC Class I in Dendritic Cell Subsets |
| Q38843602 | Crosstalk between human DC subsets promotes antibacterial activity and CD8+ T-cell stimulation in response to bacille Calmette-Guérin |
| Q36166032 | Defining human dendritic cell progenitors by multiparametric flow cytometry |
| Q37607686 | Dendritic cell targeting vaccine for HPV-associated cancer |
| Q89347786 | Dendritic cell-based immunotherapy |
| Q27000318 | Dendritic cell-targeted approaches to modulate immune dysfunction in the tumor microenvironment |
| Q38218671 | Dendritic cell-targeted vaccines |
| Q42696952 | Dendritic cell-targeted vaccines--hope or hype? |
| Q92249441 | Development and Characterization of a Preclinical Model for the Evaluation of CD205-Mediated Antigen Delivery Therapeutics in Type 1 Diabetes |
| Q38955637 | Different antigen-processing activities in dendritic cells, macrophages, and monocytes lead to uneven production of HIV epitopes and affect CTL recognition |
| Q38821711 | Differential uptake and cross-presentation of soluble and necrotic cell antigen by human DC subsets |
| Q39989398 | Distinct activation of primary human BDCA1(+) dendritic cells upon interaction with stressed or infected β cells |
| Q37195052 | Dual stimulation of antigen presenting cells using carbon nanotube-based vaccine delivery system for cancer immunotherapy |
| Q54202535 | Efficient Uptake of Recombinant Lipidated Survivin by Antigen-Presenting Cells Initiates Antigen Cross-Presentation and Antitumor Immunity. |
| Q89762172 | Endoplasmic Reticulum-Associated Degradation-Dependent Processing in Cross-Presentation and Its Potential for Dendritic Cell Vaccinations: A Review |
| Q91496410 | Engineering dendritic cell vaccines to improve cancer immunotherapy |
| Q38577698 | Functional Diversity of Human Dendritic Cells |
| Q36754182 | Functional Specialty of CD40 and Dendritic Cell Surface Lectins for Exogenous Antigen Presentation to CD8(+) and CD4(+) T Cells |
| Q40460817 | Generation of Immunity against Pathogens via Single-Domain Antibody-Antigen Constructs. |
| Q33659782 | Harnessing Human Cross-Presenting CLEC9A(+)XCR1(+) Dendritic Cells for Immunotherapy |
| Q96434459 | Human CLEC9A antibodies deliver Wilms' tumor 1 (WT1) antigen to CD141+ dendritic cells to activate naïve and memory WT1-specific CD8+ T cells |
| Q92316756 | Human Tumor-Infiltrating Dendritic Cells: From in Situ Visualization to High-Dimensional Analyses |
| Q33998442 | Human XCR1+ dendritic cells derived in vitro from CD34+ progenitors closely resemble blood dendritic cells, including their adjuvant responsiveness, contrary to monocyte-derived dendritic cells |
| Q38540521 | Human and Mouse Mononuclear Phagocyte Networks: A Tale of Two Species? |
| Q38205437 | Human dendritic cell functional specialization in steady-state and inflammation. |
| Q38561058 | Human dendritic cell subsets and function in health and disease |
| Q50125373 | Human dendritic cell subsets: an update |
| Q37500375 | Human dendritic cells (DCs) are derived from distinct circulating precursors that are precommitted to become CD1c+ or CD141+ DCs. |
| Q38162153 | Human dendritic cells - stars in the skin |
| Q57729450 | Human natural killer cells promote cross-presentation of tumor cell-derived antigens by dendritic cells |
| Q42106951 | Human skin dendritic cells can be targeted in situ by intradermal injection of antibodies against lectin receptors. |
| Q95315060 | IGF1R Axis Inhibition Restores Dendritic Cell Antitumor Response in Ovarian Cancer |
| Q50652688 | IL-10 promotes homeostatic proliferation of human CD8(+) memory T cells and, when produced by CD1c(+) DCs, shapes naive CD8(+) T-cell priming. |
| Q26777195 | Immunity to Pathogens Taught by Specialized Human Dendritic Cell Subsets |
| Q41935528 | Immunomodulatory effect of cryopreserved platelets: altered BDCA3(+) dendritic cell maturation and activation in vitro. |
| Q26738396 | Immunoregulatory functions of immune complexes in vaccine and therapy |
| Q41054995 | In situ Delivery of Antigen to DC-SIGN(+)CD14(+) Dermal Dendritic Cells Results in Enhanced CD8(+) T-Cell Responses |
| Q34046807 | Increased generation of HIV-1 gp120-reactive CD8+ T cells by a DNA vaccine construct encoding the chemokine CCL3. |
| Q26995456 | Investigating Evolutionary Conservation of Dendritic Cell Subset Identity and Functions |
| Q26866505 | Mechanisms of HIV protein degradation into epitopes: implications for vaccine design |
| Q40253946 | Modular expression analysis reveals functional conservation between human Langerhans cells and mouse cross-priming dendritic cells. |
| Q34342500 | Murine Langerin+ dermal dendritic cells prime CD8+ T cells while Langerhans cells induce cross-tolerance |
| Q92714157 | Myeloid and Plasmacytoid Dendritic Cells and Cancer - New Insights |
| Q42202638 | Nanoparticle-mediated combinatorial targeting of multiple human dendritic cell (DC) subsets leads to enhanced T cell activation via IL-15-dependent DC crosstalk. |
| Q50045412 | Phagocytosis of antibody-opsonized tumor cells leads to the formation of a discrete vacuolar compartment in macrophages. |
| Q40201595 | Platelet concentrates modulate myeloid dendritic cell immune responses. |
| Q51050849 | Primary Human Blood Dendritic Cells for Cancer Immunotherapy-Tailoring the Immune Response by Dendritic Cell Maturation. |
| Q30392181 | Redirecting soluble antigen for MHC class I cross-presentation during phagocytosis |
| Q92441659 | Role of Dendritic Cells in Exposing Latent HIV-1 for the Kill |
| Q35871590 | Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma |
| Q39014554 | Spatial separation of the processing and MHC class I loading compartments for cross-presentation of the tumor-associated antigen HER2/neu by human dendritic cells |
| Q64991307 | TLR3 agonist and CD40-targeting vaccination induces immune responses and reduces HIV-1 reservoirs. |
| Q37277188 | Targeting CLEC9A delivers antigen to human CD141(+) DC for CD4(+) and CD8(+)T cell recognition |
| Q41080657 | Targeting dendritic cells in humanized mice receiving adoptive T cells via monoclonal antibodies fused to Flu epitopes |
| Q26746162 | Targeting dendritic cells: a promising strategy to improve vaccine effectiveness |
| Q38235001 | Targeting human dendritic cells in situ to improve vaccines. |
| Q48028943 | Targeting interferon-alpha to dendritic cells enhances a CD8+ T cell response to a human CD40-targeted cancer vaccine |
| Q39104926 | The Biology and Underlying Mechanisms of Cross-Presentation of Exogenous Antigens on MHC-I Molecules |
| Q26865854 | The known unknowns of the human dendritic cell network |
| Q38214043 | The origins and functions of dendritic cells and macrophages in the skin |
| Q38193807 | The role of dendritic cells in graft-versus-tumor effect |
| Q47789519 | Towards personalized, tumour-specific, therapeutic vaccines for cancer. |
| Q34721358 | Transcriptional fingerprints of antigen-presenting cell subsets in the human vaginal mucosa and skin reflect tissue-specific immune microenvironments |
| Q42867339 | Trial watch: Dendritic cell-based interventions for cancer therapy |
| Q38176613 | Type I Interferons as Stimulators of DC-Mediated Cross-Priming: Impact on Anti-Tumor Response |
| Q38209325 | Understanding MHC class I presentation of viral antigens by human dendritic cells as a basis for rational design of therapeutic vaccines |
| Q54217613 | Understanding the Cellular Origin of the Mononuclear Phagocyte System Sheds Light on the Myeloid Postulate of Immune Paralysis in Sepsis. |
| Q38208305 | Understanding the biology of antigen cross-presentation for the design of vaccines against cancer |
| Q37547365 | Vaccination with a fusion protein that introduces HIV-1 gag antigen into a multitrimer CD40L construct results in enhanced CD8+ T cell responses and protection from viral challenge by vaccinia-gag |
| Q36394947 | Visualization of early influenza A virus trafficking in human dendritic cells using STED microscopy. |
Search more.